BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 38515208)

  • 61. Heterogeneity of breast cancer clinical characteristics and outcome in US black women--effect of place of birth.
    Camacho-Rivera M; Kalwar T; Sanmugarajah J; Shapira I; Taioli E
    Breast J; 2014; 20(5):489-95. PubMed ID: 25041223
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Impact of race and ethnicity on outcomes for estrogen receptor-negative breast cancers: experience of an academic center with a charity hospital.
    Chu QD; Burton G; Glass J; Smith MH; Li BD
    J Am Coll Surg; 2010 May; 210(5):585-92, 592-4. PubMed ID: 20421009
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Differences in breast cancer stage at diagnosis and cancer-specific survival by race and ethnicity in the United States.
    Iqbal J; Ginsburg O; Rochon PA; Sun P; Narod SA
    JAMA; 2015 Jan; 313(2):165-73. PubMed ID: 25585328
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Poor prognosis of single hormone receptor- positive breast cancer: similar outcome as triple-negative breast cancer.
    Bae SY; Kim S; Lee JH; Lee HC; Lee SK; Kil WH; Kim SW; Lee JE; Nam SJ
    BMC Cancer; 2015 Mar; 15():138. PubMed ID: 25880075
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Active smoking and survival following breast cancer among African American and non-African American women in the Carolina Breast Cancer Study.
    Parada H; Sun X; Tse CK; Olshan AF; Troester MA; Conway K
    Cancer Causes Control; 2017 Sep; 28(9):929-938. PubMed ID: 28695396
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Disparities in breast cancer: a multi-institutional comparative analysis focusing on American Hispanics.
    Nahleh Z; Otoukesh S; Mirshahidi HR; Nguyen AL; Nagaraj G; Botrus G; Badri N; Diab N; Alvarado A; Sanchez LA; Dwivedi AK
    Cancer Med; 2018 Jun; 7(6):2710-2717. PubMed ID: 29733543
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Risk Factors That Increase Risk of Estrogen Receptor-Positive and -Negative Breast Cancer.
    Kerlikowske K; Gard CC; Tice JA; Ziv E; Cummings SR; Miglioretti DL;
    J Natl Cancer Inst; 2017 May; 109(5):. PubMed ID: 28040694
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Pre-Menopausal Women With Breast Cancers Having High AR/ER Ratios in the Context of Higher Circulating Testosterone Tend to Have Poorer Outcomes.
    Rajarajan S; Korlimarla A; Alexander A; Anupama CE; Ramesh R; Srinath BS; Sridhar TS; Prabhu JS
    Front Endocrinol (Lausanne); 2021; 12():679756. PubMed ID: 34234742
    [TBL] [Abstract][Full Text] [Related]  

  • 69. A BIRC5
    Bai Y; Yuan F; Yu J; Si Y; Zheng Y; Li D
    Cancer Inform; 2022; 21():11769351221096655. PubMed ID: 35734521
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Hepatocyte growth factor pathway expression in breast cancer by race and subtype.
    Jones GS; Hoadley KA; Olsson LT; Hamilton AM; Bhattacharya A; Kirk EL; Tipaldos HJ; Fleming JM; Love MI; Nichols HB; Olshan AF; Troester MA
    Breast Cancer Res; 2021 Aug; 23(1):80. PubMed ID: 34344422
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Evaluation of Racial/Ethnic Differences in Treatment and Mortality Among Women With Triple-Negative Breast Cancer.
    Cho B; Han Y; Lian M; Colditz GA; Weber JD; Ma C; Liu Y
    JAMA Oncol; 2021 Jul; 7(7):1016-1023. PubMed ID: 33983438
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Elevated breast cancer mortality in women younger than age 40 years compared with older women is attributed to poorer survival in early-stage disease.
    Gnerlich JL; Deshpande AD; Jeffe DB; Sweet A; White N; Margenthaler JA
    J Am Coll Surg; 2009 Mar; 208(3):341-7. PubMed ID: 19317994
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Intrinsic breast tumor subtypes, race, and long-term survival in the Carolina Breast Cancer Study.
    O'Brien KM; Cole SR; Tse CK; Perou CM; Carey LA; Foulkes WD; Dressler LG; Geradts J; Millikan RC
    Clin Cancer Res; 2010 Dec; 16(24):6100-10. PubMed ID: 21169259
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Genomic profiling of breast cancer in African-American women using MammaPrint.
    Nunes RA; Wray L; Mete M; Herbolsheimer P; Smith KL; Bijelic L; Boisvert ME; Swain SM
    Breast Cancer Res Treat; 2016 Oct; 159(3):481-8. PubMed ID: 27568021
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Characterization of estrogen receptor-negative/progesterone receptor-positive breast cancer.
    Shen T; Brandwein-Gensler M; Hameed O; Siegal GP; Wei S
    Hum Pathol; 2015 Nov; 46(11):1776-84. PubMed ID: 26363528
    [TBL] [Abstract][Full Text] [Related]  

  • 76. An admixture scan in 1,484 African American women with breast cancer.
    Fejerman L; Haiman CA; Reich D; Tandon A; Deo RC; John EM; Ingles SA; Ambrosone CB; Bovbjerg DH; Jandorf LH; Davis W; Ciupak G; Whittemore AS; Press MF; Ursin G; Bernstein L; Huntsman S; Henderson BE; Ziv E; Freedman ML
    Cancer Epidemiol Biomarkers Prev; 2009 Nov; 18(11):3110-7. PubMed ID: 19843668
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Validation of cytoplasmic-to-nuclear ratio of survivin as an indicator of improved prognosis in breast cancer.
    Rexhepaj E; Jirstrom K; O'Connor DP; O'Brien SL; Landberg G; Duffy MJ; Brennan DJ; Gallagher WM
    BMC Cancer; 2010 Nov; 10():639. PubMed ID: 21092276
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Insulin resistance contributes to racial disparities in breast cancer prognosis in US women.
    Gallagher EJ; Fei K; Feldman SM; Port E; Friedman NB; Boolbol SK; Killelea B; Pilewskie M; Choi L; King T; Nayak A; Franco R; Cruz D; Antoniou IM; LeRoith D; Bickell NA
    Breast Cancer Res; 2020 May; 22(1):40. PubMed ID: 32393319
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Prognostic and predictive value of androgen receptor expression in postmenopausal women with estrogen receptor-positive breast cancer: results from the Breast International Group Trial 1-98.
    Kensler KH; Regan MM; Heng YJ; Baker GM; Pyle ME; Schnitt SJ; Hazra A; Kammler R; Thürlimann B; Colleoni M; Viale G; Brown M; Tamimi RM
    Breast Cancer Res; 2019 Feb; 21(1):30. PubMed ID: 30795773
    [TBL] [Abstract][Full Text] [Related]  

  • 80. AR negative triple negative or "quadruple negative" breast cancers in African American women have an enriched basal and immune signature.
    Davis M; Tripathi S; Hughley R; He Q; Bae S; Karanam B; Martini R; Newman L; Colomb W; Grizzle W; Yates C
    PLoS One; 2018; 13(6):e0196909. PubMed ID: 29912871
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.